FindTrial
Sign In

Delirium prevention and prediction,Part 2

Delirium prevention and prediction,Part 2 - Delirium prevention and prediction,Part 2

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000015681
Enrollment
78
Registered
2015-02-28
Start date
2015-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

delirium

Interventions

suvolexant placebo

Sponsors

Juntendo University
Lead Sponsor
Nippon Medical School Musashikosugi Hospital Hiroshima City Hospital Tokyo Medical and Dental University Kanazawa University Graduate School of Medical Science
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients newly admitted due to emergency, and able to take medicine orally

Exclusion criteria

Exclusion criteria: Patients who have an expected stay or life expectancy less than 2 night

Design outcomes

Primary

MeasureTime frame
Incidence of delirium as determined by the DSM-5.—

Secondary

MeasureTime frame
1. Estimates of the probability of developing delirium 2. Change in inflammatory markers—

Countries

Japan

Contacts

Public ContactKotaro Hatta

Juntendo University Nerima Hospital Department of Psychiatry

khatta@juntendo.ac.jp+81-3-5923-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026